Dennis Calvert, CEO of BioLargo Inc. (OTCQB: BLGO), gives an update from their annual shareholder’s meeting. They discuss developments on the first prototype for the Advanced Oxidation System filter, projected to be released in August 2016. He also mentions the wound care division, and it’s first outside investor that came on board in December 2015, which opened the door to move forward in third-party production, validation and proof of claim, all in an effort to push towards meeting FDA regulations. With that investment, they’re ready to dive right into the marketplace. Listen to the full interview here: https://upticknewswire.com/ceo-dennis-calvert...-products/
Uptick Newswire provided the above as a paid service. It is understood that investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that “a suggestion” nothing more. It is our expectation that investors will do their own due diligence. We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.